Liquidia Corporation

Liquidia Corporation Liquidia Corporation is a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease.

The company’s current focus spans the development and commercialization of products in pulmonary hypertension and other applications of its proprietary PRINT® Technology.

10/10/2025

Our patient panel is coming up on October 15. This year we will discuss gaps in care and research as well as inclusivity in trials. Hear the patient perspective on these topics--secure your spot today at https://bit.ly/3UP8vzN

Address

419 David Drive, Suite 100
Morrisville, NC
27560

Website

Alerts

Be the first to know and let us send you an email when Liquidia Corporation posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category